IndraLab

Statements


| 1

reach
"Serum levels of IFN-beta and IP-10, whose production requires activation of type I IFN signaling, were markedly reduced in Ifnar1 -/- mice treated with FK156 and low-dose cerulein as compared with those in Ifnar1 +/+ mice."